Original language | English |
---|---|
Pages (from-to) | 652-653 |
Number of pages | 2 |
Journal | Therapeutic Drug Monitoring |
Volume | 42 |
Issue number | 4 |
Early online date | 2020 |
DOIs |
|
Publication status | Published - 1-Aug-2020 |
Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): how to act
Tanja R Zijp, Martha L Toren-Wielema, Prashant V Nannan Panday, Jos G W Kosterink, Stefan P Berger, Daan J Touw*
*Corresponding author for this work
- PharmacoTherapy, Epidemiology and Economics
- Biopharmaceuticals, Discovery, Design and Delivery (BDDD)
- Groningen Kidney Center (GKC)
- Groningen Institute for Organ Transplantation (GIOT)
- Pharmaceutical Analysis
- Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
- Groningen Research Institute for Asthma and COPD (GRIAC)
- Medicinal Chemistry and Bioanalysis (MCB)
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
7
Citations
(Scopus)
129
Downloads
(Pure)